Machine Learning to mRNA: How I Built a Personalised Cancer Vaccine for My Dog

About this event

Speaker bio: • Paul Conyngham is the founder of Gamgee, a Y Combinator company developing personalised mRNA cancer vaccines for dogs. After 17 years in machine learning, Paul taught himself genomics and used AI to design a personalised vaccine for his dog Rosie, whose responsive tumours shrank by 50–75%. Presentation outline: \- Rosie’s cancer and why existing treatments were not enough \- Using AI to cross from machine learning into genomics \- The journey from tumour sequencing to an administered mRNA vaccine \- What worked\, what failed and what one patient can teach us \- Turning a year\-long manual process into repeatable software \- Why Gamgee is starting with dogs and where the technology goes next • Join our community on Linkedin https://www.linkedin.com/groups/14297125/ to stay up-to-date on all our upcoming events We are grateful to our new hosts and sponsors the Centre for Business Intelligence and Data Analytics (BIDA) at the Business School, University of Technology, Sydney